Executive Vice President, Ph.D. in Oncology, Visiting Professor at Peking University Cancer Hospital; focuses on basic and clinical translational research in oncology.
Specialties: Comprehensive treatment of systemic solid tumors; combined molecular diagnostics, targeted therapy, and immunotherapy for cancer.
Prof. Caolin, MD
| Speciality | Comprehensive treatment of solid tumors; combined molecular diagnosis, targeted therapy, and immunotherapy. |
| Affiliated Hospital : | Hebei Yizhou Cancer Hospital |
| Department : |
|
| Language : | Chinese, English |
Overview
Achievements and Experience
He went to the UK for further studies in 2003 and obtained a PhD in Oncology from the University of Aberdeen in 2007, subsequently conducting postdoctoral research at the University of California, Davis.
He specializes in the comprehensive treatment of tumors, with particular expertise in the mechanisms of tumor metastasis and drug resistance, as well as extensive experience regarding the relationship between tumor genetic characteristics and prognosis.
With 38 years of experience spanning clinical practice, scientific research, and hospital management, he has published over 30 papers in academic journals—both domestic and international—including 24 in international publications.
As the Executive Vice President of the hospital, he frequently represents the institution at academic conferences and delivers keynote presentations on topics such as advancements in proton radiotherapy for solid malignant tumors.
Main Academic Roles
- Chairperson of the Hospital Ethics Committee: Chairperson of the Clinical Trial Ethics Committee, Hebei Yizhou Cancer Hospital
- Visiting Professor, Peking University Cancer Hospital
© 2026 China Medical Services. All rights reserved.